These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20098713)

  • 1. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
    Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
    PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif.
    Yang SH; Sharrocks AD
    Mol Cell Biol; 2010 May; 30(9):2193-205. PubMed ID: 20176810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polycomb protein Pc2 is a SUMO E3.
    Kagey MH; Melhuish TA; Wotton D
    Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple activities contribute to Pc2 E3 function.
    Kagey MH; Melhuish TA; Powers SE; Wotton D
    EMBO J; 2005 Jan; 24(1):108-19. PubMed ID: 15592428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
    de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
    Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pc2 and SUMOylation.
    Wotton D; Merrill JC
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1401-4. PubMed ID: 18031231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
    Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
    Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a.
    Li B; Zhou J; Liu P; Hu J; Jin H; Shimono Y; Takahashi M; Xu G
    Biochem J; 2007 Jul; 405(2):369-78. PubMed ID: 17439403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y; Chung KC
    J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin.
    Long J; Zuo D; Park M
    J Biol Chem; 2005 Oct; 280(42):35477-89. PubMed ID: 16061479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
    Tripathi V; Chatterjee KS; Das R
    J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncovalent SUMO-interaction motifs in HIV integrase play important roles in SUMOylation, cofactor binding, and virus replication.
    Zheng Y; Jayappa KD; Ao Z; Qiu X; Su RC; Yao X
    Virol J; 2019 Apr; 16(1):42. PubMed ID: 30940169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CTCF insulator protein is posttranslationally modified by SUMO.
    MacPherson MJ; Beatty LG; Zhou W; Du M; Sadowski PD
    Mol Cell Biol; 2009 Feb; 29(3):714-25. PubMed ID: 19029252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation of Argonaute-2 regulates RNA interference activity.
    Josa-Prado F; Henley JM; Wilkinson KA
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1066-1071. PubMed ID: 26188511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
    Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
    Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.